Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Scientists collaborate at the January 2018 NCATS Data Hackathon

Collaborative Approach to Advancing Biomedical Data Sharing

NCATS is connecting academic and private-sector partners to create a data-mining resource to speed translational innovation in disease prevention, diagnosis and treatment.

Super resolution image of a group of killer T cells surrounding a cancer cell

NCATS Furthers Efforts to Create a Data Ecosystem

Biomedical Data Translator scientists aim to create a computational tool to improve connections among biomedical data types and provide insights into disease biology and treatments.

Work With Us

Learn more about how you can access funding and collaborate with NCATS through the Biomedical Data Translator program.

Contact Translator staff (link sends e-mail)

Biomedical Data Translator

NCATS launched the Biomedical Data Translator (Translator) program to accelerate biomedical translation for the research community. Through this program, NCATS will integrate existing biomedical data to help reveal new relationships within those data and also identify novel opportunities for research. Learn more.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

About Biomedical Data Translator

Learn more about the Biomedical Data Translator program and its objectives.

Funding Information

Find out how to apply for Biomedical Data Translator funding.

Translator Projects

Access details about ongoing Biomedical Data Translator projects.

Building a Data Translator

NCATS launched the Biomedical Data Translator program as a multiyear, iterative effort toward the eventual development of a comprehensive, relational, N-dimensional “data translator” that integrates multiple types of existing data sources. These sources may include objective signs and symptoms of disease, drug effects, and intervening types of biological data relevant to understanding pathophysiology. The Translator could enable a significant shift from the current symptom-based diagnosis of disease classification to one that is based on a set of molecular and cellular abnormalities that can be targeted by various preventative and therapeutic interventions.

The Translator program is funded through the Cures Acceleration Network (CAN). CAN is designed to advance the development of high-need cures and reduce significant barriers between research discovery and clinical trials. Learn more about the Biomedical Data Translator program.